[Form 4] Brunswick Corporation Insider Trading Activity

Rhea-AI Filing Summary

Brunswick Corp (BC) Form 4 highlights: Independent director Lauren Patricia Flaherty acquired 718 common shares on 31-Jul-2025 at $58.29 each, a transaction worth roughly $41.9 k. The shares were deposited into the board member’s deferred compensation account and will be released in scheduled installments once she is no longer a director.

After the purchase, Flaherty’s direct holdings rise to 15,607 shares, which include 114 shares obtained through the June 2025 dividend-reinvestment program. No sales or derivative-security trades were reported, and the filing contains no other material corporate events. While the dollar amount is modest relative to Brunswick’s market value, the net addition represents a small vote of confidence by an outside board member.

Insights

Equity Analyst

TL;DR: Small insider buy; immaterial to valuation, mildly positive signal.

The purchase adds just 0.004% to outstanding shares and about 0.3% to the director’s personal stake, so it will not move the stock. However, insiders rarely buy if they expect near-term weakness; even routine deferred-share accrual suggests alignment with shareholders. Given Brunswick’s cyclical marine exposure, any insider accumulation is worth monitoring, but this single trade is too small to alter an investment thesis.

Corporate Governance Specialist

TL;DR: Routine board-compensation deferral; governance practices appear standard.

The shares were credited via the company’s director deferred-compensation plan, a common mechanism to foster long-term alignment. No preferential pricing or accelerated vesting terms are disclosed, indicating compliance with Section 16 and best-practice disclosure. The absence of derivative transactions lowers complexity and potential dilution risk. Overall impact on governance perception is neutral-to-slightly positive.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright MaryAnn

(Last) (First) (Middle)

C/O BRUNSWICK CORPORATION

26125 N. RIVERWOODS BLVD. #500

(Street)

METTAWA IL 60045

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2025		A		745(1)	A	$58.29	9,195(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.

2. Beneficial holdings include 65 shares acquired pursuant to dividend reinvestment in June 2025.

Remarks:

	By: Power of Attorney: /s/MaryAnn Wright	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.